From Evestra Signs Deal with Glemark for Generic Version of NuvaRing:

Circle—

Stock image by Unsplash user Samuel Zeller. Used in accordance with Unsplash creative commons license https://unsplash.com/license https://unsplash.com/search/circle?photo=ai9UgH6Wzr0

Underwriters and Partners

Xconomy Insight

From Our Editors · Special Report
Biopharma and Tech Innovators Summer 2020
The cutting-edge companies behind the innovations disrupting biopharma and revolutionizing the healthcare landscape

From Our Editors · Special Report
Containing Coronavirus Through Innovation and Investment
Top biotech and investment players offer their best plans and current progress in stemming and ultimately defeating the worldwide pandemic

From Our Editors · Special Report
Xcelerating Life Sciences Boston: Special Report
Biopharma's Future in Digital Health

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy Boston

The 2020 National Xconomy Awards Expands, Goes Virtual & Reopens Nomination Period

BioNTech's mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity

Biogen Alzheimer’s Drug in FDA's Court Following Completion of Filing

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data

NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep

Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better

VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs

On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO

Alpine Immune Sciences Lands AbbVie as R&D Partner for Lupus Drug

Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

Viela Bio Gets FDA Green Light for Rare Autoimmune Disease Treatment

Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage

Akili Interactive’s Video Game for ADHD Gets the FDA All Clear

Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage

The 2020 National Xconomy Awards

Xcelerating Life Sciences Seattle

Xcelerating Life Sciences New York

From Evestra Signs Deal with Glemark for Generic Version of NuvaRing:

Underwriters and Partners

Biopharma and Tech Innovators Summer 2020

Containing Coronavirus Through Innovation and Investment

Xcelerating Life Sciences Boston: Special Report

Xconomy on Demand

We offer a number of ways to subscribe for free!